NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $600,665 | -38.3% | 231,917 | -2.8% | 0.00% | -100.0% |
| Q1 2023 | $973,145 | -20.5% | 238,516 | -2.2% | 0.00% | 0.0% |
| Q4 2022 | $1,224,152 | -64.4% | 243,855 | -7.2% | 0.00% | -50.0% |
| Q3 2022 | $3,439,000 | +1.6% | 262,851 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $3,384,000 | +29.1% | 263,912 | +53.5% | 0.00% | +100.0% |
| Q1 2022 | $2,622,000 | -12.0% | 171,894 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $2,979,000 | -19.6% | 168,244 | -4.5% | 0.00% | -50.0% |
| Q3 2021 | $3,705,000 | +22.9% | 176,235 | +15.3% | 0.00% | +100.0% |
| Q2 2021 | $3,014,000 | -60.8% | 152,854 | -42.3% | 0.00% | -75.0% |
| Q1 2021 | $7,694,000 | +1327.5% | 264,702 | +1389.1% | 0.00% | – |
| Q4 2020 | $539,000 | +160.4% | 17,776 | +36.8% | 0.00% | – |
| Q3 2020 | $207,000 | -11.5% | 12,990 | +9.6% | 0.00% | – |
| Q2 2020 | $234,000 | +93.4% | 11,854 | +21.0% | 0.00% | – |
| Q1 2020 | $121,000 | -26.7% | 9,797 | +9.1% | 0.00% | – |
| Q4 2019 | $165,000 | +534.6% | 8,978 | +343.8% | 0.00% | – |
| Q3 2019 | $26,000 | -46.9% | 2,023 | -40.3% | 0.00% | – |
| Q2 2019 | $49,000 | – | 3,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |